NO862373L - Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.

Info

Publication number
NO862373L
NO862373L NO862373A NO862373A NO862373L NO 862373 L NO862373 L NO 862373L NO 862373 A NO862373 A NO 862373A NO 862373 A NO862373 A NO 862373A NO 862373 L NO862373 L NO 862373L
Authority
NO
Norway
Prior art keywords
formula
compound
give
methyl
mixture
Prior art date
Application number
NO862373A
Other languages
English (en)
Norwegian (no)
Other versions
NO862373D0 (no
Inventor
Roy Victor Davies
James Fraser
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO862373D0 publication Critical patent/NO862373D0/no
Publication of NO862373L publication Critical patent/NO862373L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO862373A 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. NO862373L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515207A GB8515207D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO862373D0 NO862373D0 (no) 1986-06-13
NO862373L true NO862373L (no) 1986-12-16

Family

ID=10580803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862373A NO862373L (no) 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.

Country Status (20)

Country Link
US (1) US4710506A (da)
EP (1) EP0209977A3 (da)
JP (1) JPS6236382A (da)
KR (1) KR870000339A (da)
AU (1) AU581595B2 (da)
CS (1) CS258483B2 (da)
DD (1) DD253823A5 (da)
DK (1) DK272486A (da)
ES (1) ES8707243A1 (da)
FI (1) FI862520A (da)
GB (1) GB8515207D0 (da)
GR (1) GR861527B (da)
HU (1) HU195661B (da)
JO (1) JO1482B1 (da)
NO (1) NO862373L (da)
PH (1) PH22293A (da)
PL (1) PL266392A1 (da)
PT (1) PT82759B (da)
YU (2) YU99386A (da)
ZA (1) ZA864396B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US6995171B2 (en) * 2001-06-21 2006-02-07 Agouron Pharmaceuticals, Inc. Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
CN100413861C (zh) * 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
ES2392897T3 (es) * 2006-09-26 2012-12-14 Crestone, Inc. Compuestos tienopiridona sustituidos con actividad antibacteriana
EP2559692A1 (en) 2006-11-15 2013-02-20 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of Flavivirus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CS436286A2 (en) 1987-12-17
DK272486D0 (da) 1986-06-10
JPS6236382A (ja) 1987-02-17
EP0209977A2 (en) 1987-01-28
HUT42775A (en) 1987-08-28
ES8707243A1 (es) 1987-07-16
GB8515207D0 (en) 1985-07-17
CS258483B2 (en) 1988-08-16
ZA864396B (en) 1987-08-26
FI862520A0 (fi) 1986-06-12
NO862373D0 (no) 1986-06-13
EP0209977A3 (en) 1988-06-08
HU195661B (en) 1988-06-28
AU581595B2 (en) 1989-02-23
DD253823A5 (de) 1988-02-03
FI862520A (fi) 1986-12-16
US4710506A (en) 1987-12-01
PL266392A1 (en) 1988-02-18
GR861527B (en) 1986-10-14
KR870000339A (ko) 1987-02-17
YU99386A (en) 1988-04-30
AU5838386A (en) 1986-12-18
JO1482B1 (en) 1988-03-10
YU121187A (en) 1988-04-30
PT82759A (en) 1986-07-01
PH22293A (en) 1988-07-22
DK272486A (da) 1986-12-16
ES556026A0 (es) 1987-07-16
PT82759B (en) 1988-05-12

Similar Documents

Publication Publication Date Title
NO862373L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
CA1134362A (en) Benzimidazoles, their preparation and their use as pharmaceutical compositions
AU605363B2 (en) 4H-1-benzopyran-4-one derivative or its salt, processes for producing the same and pharmaceutical composition comprising the same as active ingredient
US4690930A (en) Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one derivatives and their use as psychotropic agents
RU2129549C1 (ru) Производные пиримидина и способы их получения
EP0465254B1 (en) Fused thiophene compounds and uses thereof
US4353827A (en) Diazepine derivatives
AU683492B2 (en) Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
JP2003513099A (ja) ピラゾールカルボン酸の三環式誘導体、その製造法およびそれを含む医薬組成物
JPWO2006083005A1 (ja) 縮合ピリミジン誘導体およびその用途
MXPA02002111A (es) Compuestos de sulfonilfenilpirazol utiles como inhibidores de cox-2.
CS187391A3 (en) Heterocyclic derivatives, process for their preparation and their use as medicaments
CA2116286A1 (en) N-heteroaryl-n'-phenylurea derivatives, their production and use
NZ552283A (en) New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
IE912114A1 (en) Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
JPS6157587A (ja) 縮合複素環誘導体および抗潰瘍剤
HU207999B (en) Process for producing quinazolin-3-alkanoic acids and pharmaceutical compositions containing them
NO162414B (no) Fleksibel beholder for transport og lagring av massegods.
US6472416B1 (en) Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
KR20020049051A (ko) 포스포디에스테라제 ⅶ 억제제로서의 이미다졸 화합물
CZ17988A3 (en) BENZOPYRAN(4,3-c)PYRAZOLE OR BENZOTHIOPYRAN(4,3-c)PYRAZOLE DERIVATIVES, PROCESSES OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE COMPRISED
FI79319B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tricykliska oxindolkarboxamidderivat.
FI67550B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,10-dihydro-4-piperazinyl-pyrazolo(3,4-b)(1,5)bensodiazepinderivat
NO176142B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
CA2168739A1 (en) Fused tricyclic heteroaromatic derivatives